Your browser doesn't support javascript.
loading
Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors.
Travier, Noemie; Buckland, Genevieve; Vendrell, Joan J; Fernandez-Veledo, Sonia; Peiró, Immaculada; Del Barco, Sonia; Pernas, Sonia; Zamora, Esther; Bellet, Meritxell; Margeli, Mireia; Cirauqui, Beatriz; Muñoz, Montserrat; Tusquets, Ignasi; Arcusa, Angels; Javierre, Casimiro; Moreno, Ferran; Rodriguez, Ana; Agudo, Antonio.
Affiliation
  • Travier N; Cancer Prevention and Control Programme, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
  • Buckland G; Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
  • Vendrell JJ; Diabetes and Metabolic Associated Diseases Research Group, Hospital Joan XXIII, School of Medicine, Rovira i Virgili University, Tarragona, Spain.
  • Fernandez-Veledo S; Diabetes and Metabolic Associated Diseases Research Group, Hospital Joan XXIII, School of Medicine, Rovira i Virgili University, Tarragona, Spain.
  • Peiró I; Clinical Nutrition Unit, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
  • Del Barco S; Department of Medical Oncology-ICO, Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain.
  • Pernas S; Breast Cancer Functional Unit, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
  • Zamora E; Vall d'Hebron Institute of Oncology (VHIO), Breast Cancer Unit, Department of Medical Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Bellet M; Vall d'Hebron Institute of Oncology (VHIO), Breast Cancer Unit, Department of Medical Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Margeli M; Department of Medical Oncology-ICO, Hospital Germans Trias i Pujol, Barcelona, Spain.
  • Cirauqui B; Department of Medical Oncology-ICO, Hospital Germans Trias i Pujol, Barcelona, Spain.
  • Muñoz M; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.
  • Tusquets I; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.
  • Arcusa A; Department of Medical Oncology, Consorci Sanitari de Terrassa, Terrassa, Spain.
  • Javierre C; Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Spain.
  • Moreno F; Breast Cancer Functional Unit, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
  • Rodriguez A; Breast Cancer Functional Unit, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
  • Agudo A; Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
Eur J Cancer Care (Engl) ; 27(4): e12861, 2018 Jul.
Article in En | MEDLINE | ID: mdl-29869823
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Insulin Resistance / Exercise / Leptin / Risk Reduction Behavior / Diet Therapy / Overweight / Adiponectin / Cancer Survivors / Obesity Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Eur J Cancer Care (Engl) Journal subject: ENFERMAGEM / NEOPLASIAS Year: 2018 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Insulin Resistance / Exercise / Leptin / Risk Reduction Behavior / Diet Therapy / Overweight / Adiponectin / Cancer Survivors / Obesity Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Eur J Cancer Care (Engl) Journal subject: ENFERMAGEM / NEOPLASIAS Year: 2018 Type: Article Affiliation country: Spain